| 1 |
35450042 | Ribociclib Inhibits P-gp-Mediated Multidrug Resistance in Human Epidermoid Carcinoma Cells. | 2022 |
1 |
| 2 |
33821673 | Recent advances in research of colchicine binding site inhibitors and their interaction modes with tubulin. | 2021 May |
1 |
| 3 |
33961006 | Colchicine and the heart. | 2021 Jul 21 |
1 |
| 4 |
32274687 | Evidence of Clinically Meaningful Drug-Drug Interaction With Concomitant Use of Colchicine and Clarithromycin. | 2020 Jul |
2 |
| 5 |
32999162 | Prescription of Colchicine with Other Dangerous Concomitant Medications: A Nation-Wide Survey Using the Japanese Claims Database. | 2020 |
4 |
| 6 |
31178824 | Colchicine Myopathy: A Case Series Including Muscle MRI and ABCB1 Polymorphism Data. | 2019 |
4 |
| 7 |
31515284 | A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein. | 2019 Nov |
1 |
| 8 |
31569420 | Development of an Aryloxazole Derivative as a Brain-Permeable Anti-Glioblastoma Agent. | 2019 Sep 28 |
1 |
| 9 |
28576750 | BZML, a novel colchicine binding site inhibitor, overcomes multidrug resistance in A549/Taxol cells by inhibiting P-gp function and inducing mitotic catastrophe. | 2017 Aug 28 |
1 |
| 10 |
29299132 | Saikosaponins A, C and D enhance liver-targeting effects of anticancer drugs by modulating drug transporters. | 2017 Dec 15 |
3 |
| 11 |
27262378 | Ferulic acid reverses ABCB1-mediated paclitaxel resistance in MDR cell lines. | 2016 Sep 5 |
1 |
| 12 |
24180297 | Relationship between response to colchicine treatment and MDR1 polymorphism in familial Mediterranean fever patients. | 2014 Feb |
5 |
| 13 |
24284783 | β-Elemene, a compound derived from Rhizoma zedoariae, reverses multidrug resistance mediated by the ABCB1 transporter. | 2014 Feb |
1 |
| 14 |
24295377 | Tivozanib reverses multidrug resistance mediated by ABCB1 (P-glycoprotein) and ABCG2 (BCRP). | 2014 Aug |
1 |
| 15 |
24378930 | Safety profile of anti-gout agents: an update. | 2014 Mar |
2 |
| 16 |
24452746 | Effect of steady-state atorvastatin on the pharmacokinetics of a single dose of colchicine in healthy adults under fasted conditions. | 2014 Apr |
2 |
| 17 |
24759273 | Colchicine effect on P-glycoprotein expression and activity: in silico and in vitro studies. | 2014 Jul 25 |
11 |
| 18 |
24983126 | Radiosynthesis and biological evaluation of 68Ga-labeled colchicine conjugates. | 2014 Aug |
3 |
| 19 |
23408444 | Lack of an effect of CYP3A4 and MDR1 gene polymorphisms on colchicine pharmacogenetics in the treatment of Familial Mediterranean fever. | 2013 Jan 24 |
3 |
| 20 |
21982683 | YHHU0895, a novel synthetic small-molecule microtubule-destabilizing agent, effectively overcomes P-glycoprotein-mediated tumor multidrug resistance. | 2012 Jan 1 |
1 |
| 21 |
22705826 | MDR1 gene polymorphisms may be associated with Behçet's disease and its colchicum treatment response. | 2012 Sep 1 |
1 |
| 22 |
23146540 | Severe colchicine intoxication in a renal transplant recipient on cyclosporine. | 2012 Nov |
1 |
| 23 |
23198691 | Colchicine protects dopaminergic neurons in a rat model of Parkinson's disease. | 2012 Nov 1 |
1 |
| 24 |
21218380 | Investigation of ABCB1 gene polymorphism with colchicine response in Behçet's disease. | 2011 Jan 4 |
5 |
| 25 |
21480191 | Novel evidence-based colchicine dose-reduction algorithm to predict and prevent colchicine toxicity in the presence of cytochrome P450 3A4/P-glycoprotein inhibitors. | 2011 Aug |
3 |
| 26 |
21851199 | Association between ABCB1 (MDR1) gene 3435 C>T polymorphism and colchicine unresponsiveness of FMF patients. | 2011 |
4 |
| 27 |
19777523 | Activators of P-glycoprotein: Structure-activity relationships and investigation of their mode of action. | 2009 Nov |
1 |
| 28 |
17122416 | Actin disruption inhibits endosomal traffic of P-glycoprotein-EGFP and resistance to daunorubicin accumulation. | 2007 Apr |
1 |
| 29 |
17610314 | Association of drug transporter gene ABCB1 (MDR1) 3435C to T polymorphism with colchicine response in familial Mediterranean fever. | 2007 Jul |
8 |
| 30 |
16565061 | Interaction of transported drugs with the lipid bilayer and P-glycoprotein through a solvation exchange mechanism. | 2006 Jun 1 |
2 |
| 31 |
16978677 | Is P-glycoprotein (ABCB1) a phase 0 or a phase 3 colchicine transporter depending on colchicine exposure conditions? | 2006 Dec 1 |
9 |
| 32 |
17067838 | Colchicine today. | 2006 Dec |
3 |
| 33 |
15671173 | Intercellular transfer of P-glycoprotein mediates acquired multidrug resistance in tumor cells. | 2005 Feb 8 |
1 |
| 34 |
15964250 | P-glycoprotein expression increases ATP release in respiratory cystic fibrosis cells. | 2005 Sep |
1 |
| 35 |
15049699 | Improved energy coupling of human P-glycoprotein by the glycine 185 to valine mutation. | 2004 Apr 6 |
5 |
| 36 |
15110230 | P-glycoprotein in autoimmune diseases. | 2004 Mar |
1 |
| 37 |
15122583 | MRP1 and glucosylceramide are coordinately over expressed and enriched in rafts during multidrug resistance acquisition in colon cancer cells. | 2004 Jul 1 |
3 |
| 38 |
15388989 | Topical colchicine selection of keratinocytes transduced with the multidrug resistance gene (MDR1) can sustain and enhance transgene expression in vivo. | 2004 |
1 |
| 39 |
15494379 | Acute colchicine intoxication during clarithromycin administration. | 2004 Dec |
3 |
| 40 |
12948018 | Efflux ratio cannot assess P-glycoprotein-mediated attenuation of absorptive transport: asymmetric effect of P-glycoprotein on absorptive and secretory transport across Caco-2 cell monolayers. | 2003 Aug |
1 |
| 41 |
11809686 | In vivo analysis of human multidrug resistance protein 1 (MRP1) activity using transient expression of fluorescently tagged MRP1. | 2002 Jan 15 |
1 |
| 42 |
11812285 | In vitro-packaged SV40 pseudovirions as highly efficient vectors for gene transfer. | 2002 Jan 20 |
1 |
| 43 |
11945073 | Enhancement of transgene expression by combining glucocorticoids and anti-mitotic agents during transient transfection using DNA-cationic liposomes. | 2002 Apr |
4 |
| 44 |
11970764 | Noninvasive detection of multidrug resistance in patients with hematological malignancies: are we there yet? | 2002 Mar |
1 |
| 45 |
12235361 | Topical colchicine selection of keratinocytes transduced with the multidrug resistance gene (MDR1) can sustain and enhance transgene expression in vivo. | 2002 Oct 1 |
6 |
| 46 |
12415630 | P-glycoprotein expression by cancer cells affects cell cytotoxicity and cell-cycle perturbations induced by six chemotherapeutic drugs. | 2002 May-Jun |
1 |
| 47 |
11284688 | P-glycoprotein-mediated colchicine resistance in different cell lines correlates with the effects of colchicine on P-glycoprotein conformation. | 2001 Apr 10 |
11 |
| 48 |
11391629 | Reversal of drug resistance mediated by multidrug resistance protein (MRP) 1 by dual effects of agosterol A on MRP1 function. | 2001 Jul 1 |
2 |
| 49 |
11465412 | P-glycoprotein inhibition leads to enhanced disruptive effects by anti-microtubule cytostatics at the in vitro blood-brain barrier. | 2001 May |
2 |
| 50 |
27419877 | Imaging Multidrug Resistance in Hematological Malignancies. | 2001 |
1 |